Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2321Neoplasms 1688Prostatic Neoplasms 1187Lung Neoplasms 914Colorectal Neoplasms 875Carcinoma, Non-Small-Cell Lung 849Leukemia, Myeloid, Acute 585Pancreatic Neoplasms 573Multiple Myeloma 545Carcinoma, Hepatocellular 515Brain Neoplasms 513Neoplasm Metastasis 462Head and Neck Neoplasms 459Melanoma 414Ovarian Neoplasms 409Glioblastoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 388Stomach Neoplasms 371Uterine Cervical Neoplasms 359Squamous Cell Carcinoma of Head and Neck 356Rectal Neoplasms 335Recurrence 334Hematologic Neoplasms 327Sarcoma 324Lymphoma 314Colonic Neoplasms 314Triple Negative Breast Neoplasms 285Urinary Bladder Neoplasms 283Glioma 278Carcinoma, Renal Cell 278

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hyperplasia × 1 year × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT02333435 2025-11-20

RCT-EPA

CHU de Quebec-Universite Laval

Phase 2 Active not recruiting
130 enrolled
Genitourinary

Hyperplasia, Inflammation, Prostatic Neoplasms

NCT05623748 2025-09-24

Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs)

Chang Gung Memorial Hospital

Completed
160 enrolled

Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡